{ "access": { "embargo": { "active": false, "reason": null }, "files": "public", "record": "public", "status": "open" }, "created": "2021-06-14T15:22:38.666674+00:00", "custom_fields": { "journal:journal": { "title": "the BMJ" } }, "deletion_status": { "is_deleted": false, "status": "P" }, "files": { "count": 1, "enabled": true, "entries": { "2021 - Li - Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries multinational network cohort study.pdf": { "checksum": "md5:a02321cbc04f3e66351ca86df645407b", "ext": "pdf", "id": "9780acf0-e2dc-4cf5-b31b-6006ff3a9c4c", "key": "2021 - Li - Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries multinational network cohort study.pdf", "metadata": null, "mimetype": "application/pdf", "size": 603640 } }, "order": [], "total_bytes": 603640 }, "id": "4946542", "is_draft": false, "is_published": true, "links": { "access": "https://zenodo.org/api/records/4946542/access", "access_links": "https://zenodo.org/api/records/4946542/access/links", "access_request": "https://zenodo.org/api/records/4946542/access/request", "access_users": "https://zenodo.org/api/records/4946542/access/users", "archive": "https://zenodo.org/api/records/4946542/files-archive", "archive_media": "https://zenodo.org/api/records/4946542/media-files-archive", "communities": "https://zenodo.org/api/records/4946542/communities", "communities-suggestions": "https://zenodo.org/api/records/4946542/communities-suggestions", "doi": "https://doi.org/10.1136/bmj.n1435", "draft": "https://zenodo.org/api/records/4946542/draft", "files": "https://zenodo.org/api/records/4946542/files", "latest": "https://zenodo.org/api/records/4946542/versions/latest", "latest_html": "https://zenodo.org/records/4946542/latest", "media_files": "https://zenodo.org/api/records/4946542/media-files", "parent": "https://zenodo.org/api/records/4946541", "parent_doi": "https://zenodo.org/doi/", "parent_html": "https://zenodo.org/records/4946541", "requests": "https://zenodo.org/api/records/4946542/requests", "reserve_doi": "https://zenodo.org/api/records/4946542/draft/pids/doi", "self": "https://zenodo.org/api/records/4946542", "self_doi": "https://zenodo.org/doi/10.1136/bmj.n1435", "self_html": "https://zenodo.org/records/4946542", "self_iiif_manifest": "https://zenodo.org/api/iiif/record:4946542/manifest", "self_iiif_sequence": "https://zenodo.org/api/iiif/record:4946542/sequence/default", "versions": "https://zenodo.org/api/records/4946542/versions" }, "media_files": { "count": 0, "enabled": false, "entries": {}, "order": [], "total_bytes": 0 }, "metadata": { "creators": [ { "person_or_org": { "family_name": "Xintong Li", "name": "Xintong Li", "type": "personal" } }, { "person_or_org": { "family_name": "Anna Ostropolets", "name": "Anna Ostropolets", "type": "personal" } }, { "person_or_org": { "family_name": "Rupa Makadia", "name": "Rupa Makadia", "type": "personal" } }, { "person_or_org": { "family_name": "Azza Shoaibi", "name": "Azza Shoaibi", "type": "personal" } }, { "person_or_org": { "family_name": "Gowtham Rao", "name": "Gowtham Rao", "type": "personal" } }, { "person_or_org": { "family_name": "Anthony G Sena", "name": "Anthony G Sena", "type": "personal" } }, { "person_or_org": { "family_name": "Eugenia Martinez-Hernandez", "name": "Eugenia Martinez-Hernandez", "type": "personal" } }, { "person_or_org": { "family_name": "Antonella Delmestri", "name": "Antonella Delmestri", "type": "personal" } }, { "person_or_org": { "family_name": "Katia Verhamme", "name": "Katia Verhamme", "type": "personal" } }, { "person_or_org": { "family_name": "Peter R Rijnbeek", "name": "Peter R Rijnbeek", "type": "personal" } }, { "person_or_org": { "family_name": "Talita Duarte-Salles", "name": "Talita Duarte-Salles", "type": "personal" } }, { "person_or_org": { "family_name": "Marc A Suchard", "name": "Marc A Suchard", "type": "personal" } }, { "person_or_org": { "family_name": "Patrick B Ryan", "name": "Patrick B Ryan", "type": "personal" } }, { "person_or_org": { "family_name": "George Hripcsak", "name": "George Hripcsak", "type": "personal" } }, { "person_or_org": { "family_name": "Daniel Prieto-Alhambra", "name": "Daniel Prieto-Alhambra", "type": "personal" } } ], "description": "
Objective - To quantify the background incidence rates of 15 prespecified adverse events of special interest (AESIs) associated with covid-19 vaccines.
\n\nDesign - Multinational network cohort study.
\n\nSetting - Electronic health records and health claims data from eight countries: Australia, France, Germany, Japan, the Netherlands, Spain, the United Kingdom, and the United States, mapped to a common data model.
\n\nParticipants - 126 661 070 people observed for at least 365 days before 1 January 2017, 2018, or 2019 from 13 databases.
\n\nMain outcome measures - Events of interests were 15 prespecified AESIs (non-haemorrhagic and haemorrhagic stroke, acute myocardial infarction, deep vein thrombosis, pulmonary embolism, anaphylaxis, Bell’s palsy, myocarditis or pericarditis, narcolepsy, appendicitis, immune thrombocytopenia, disseminated intravascular coagulation, encephalomyelitis (including acute disseminated encephalomyelitis), Guillain-Barré syndrome, and transverse myelitis). Incidence rates of AESIs were stratified by age, sex, and database. Rates were pooled across databases using random effects meta-analyses and classified according to the frequency categories of the Council for International Organizations of Medical Sciences.
\n\nResults - Background rates varied greatly between databases. Deep vein thrombosis ranged from 387 (95% confidence interval 370 to 404) per 100 000 person years in UK CPRD GOLD data to 1443 (1416 to 1470) per 100 000 person years in US IBM MarketScan Multi-State Medicaid data among women aged 65 to 74 years. Some AESIs increased with age. For example, myocardial infarction rates in men increased from 28 (27 to 29) per 100 000 person years among those aged 18-34 years to 1400 (1374 to 1427) per 100 000 person years in those older than 85 years in US Optum electronic health record data. Other AESIs were more common in young people. For example, rates of anaphylaxis among boys and men were 78 (75 to 80) per 100 000 person years in those aged 6-17 years and 8 (6 to 10) per 100 000 person years in those older than 85 years in Optum electronic health record data. Meta-analytic estimates of AESI rates were classified according to age and sex.
\n\nConclusion - This study found large variations in the observed rates of AESIs by age group and sex, showing the need for stratification or standardisation before using background rates for safety surveillance. Considerable population level heterogeneity in AESI rates was found between databases.
", "funding": [ { "award": { "acronym": "EHDEN", "id": "00k4n6c32::806968", "identifiers": [ { "identifier": "https://cordis.europa.eu/projects/806968", "scheme": "url" } ], "number": "806968", "program": "H2020", "title": { "en": "European Health Data and Evidence Network" } }, "funder": { "id": "00k4n6c32", "name": "European Commission" } } ], "publication_date": "2021-06-03", "publisher": "Zenodo", "resource_type": { "id": "publication-article", "title": { "de": "Zeitschriftenartikel", "en": "Journal article" } }, "rights": [ { "description": { "en": "The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited." }, "icon": "cc-by-icon", "id": "cc-by-4.0", "props": { "scheme": "spdx", "url": "https://creativecommons.org/licenses/by/4.0/legalcode" }, "title": { "en": "Creative Commons Attribution 4.0 International" } } ], "subjects": [ { "subject": "Characterisation" }, { "subject": "incidence" }, { "subject": "adverse events" }, { "subject": "COVID-19" } ], "title": "Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study" }, "parent": { "access": { "owned_by": { "user": 124723 } }, "communities": { "entries": [ { "access": { "member_policy": "open", "members_visibility": "public", "record_policy": "open", "review_policy": "open", "visibility": "public" }, "children": { "allow": false }, "created": "2020-07-23T14:48:09.937485+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "id": "0bef1a2b-0c8d-4bb7-afa1-8007d1fb02cc", "links": {}, "metadata": { "curation_policy": "Addition to the community are curated by the project management office.
\r\n", "page": "Europe is generating huge amounts of patient-level information contained in Electronic Health Record (EHR) systems and other types of health databases. These include structured data in the form of diagnoses, medications, laboratory test results, etc., and unstructured data in clinical narratives. The Electronic Health Data and Evidence Network (EHDEN) Consortium leverages these vast volumes of data to improve future clinical practice and individual patient outcomes by increasing our understanding of disease and treatment pathways. EHDEN galvanizes transparent and reproducible analytics that generate valid real-world evidence to improve patient care, and enable medical outcomes-based research at an unprecedented scale.
\r\n\r\nThe core of EHDEN is the use of a common data model (OMOP-CDM), and transparent open-source analytics developed in close collaboration with the Observational Health Data Science and Information (OHDSI) initiative.
\r\n\r\nThe objective of the EHDEN consortium is to provide all the necessary services that enable a distributed European data network to perform fast, scalable and highly reproducible research, while respecting privacy regulations, local data provenance and governance. This will include services and tools to perform data standardization, analytical pipelines, tools to share study results, and tools for stakeholder engagement and training such as the EHDEN Academy.
\r\n\r\nThe EHDEN Consortium combines active participation of stakeholder representatives with proven experience in: a) integrating different data types, methods and technologies to utilize diverse clinical datasets; b) platform development to make methods and datasets Findable, Accessible, Interoperable and Reusable (FAIR); and c) engaging a wide variety of stakeholders, including health technology assessment agencies, regulators and patients.
", "title": "European Health Data and Evidence Network" }, "revision_id": 0, "slug": "ehden", "updated": "2020-08-18T09:50:02.210959+00:00" }, { "access": { "member_policy": "open", "members_visibility": "public", "record_policy": "open", "review_policy": "open", "visibility": "public" }, "children": { "allow": false }, "created": "2020-07-20T10:28:59.216871+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "id": "90b861a2-0407-4aa9-8525-069533011146", "links": {}, "metadata": { "curation_policy": "Contributions to the community will be curated by the group lead.
\r\n", "page": "The Health Data Science (HDS) group aims to develop analytical methods and tools to enable data-driven healthcare. We apply advanced machine learning and statistical methods to develop clinical prediction models at scale in distributed data networks, develop tools for characterisation of patient populations, and pipelines for population-level effect estimation.
\r\n\r\nIn this Zenodo the latest articles of the group can be found. For more publications visit the profiles of the group members here.
", "title": "Health Data Science Group Erasmus MC" }, "revision_id": 0, "slug": "hds", "updated": "2020-10-17T12:08:21.302546+00:00" }, { "access": { "member_policy": "open", "members_visibility": "public", "record_policy": "open", "review_policy": "open", "visibility": "public" }, "children": { "allow": false }, "created": "2020-08-31T15:21:54.625518+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "id": "b363ec34-ac0c-428b-b41a-3b7152593284", "links": {}, "metadata": { "curation_policy": "OHDSI promotes open science and welcomes collaborators from all backgrounds to participate in our research community.
\r\n", "page": "The Observational Health Data Sciences and Informatics (or OHDSI, pronounced "Odyssey") program is a multi-stakeholder, interdisciplinary collaborative to bring out the value of health data through large-scale analytics. All our solutions are open-source.
\r\n\r\nOHDSI has established an international network of researchers and observational health databases with a central coordinating center housed at Columbia University.
\r\n\r\nMission: Improving health by empowering a community to collaboratively generate evidence that promotes better health decisions and better care
\r\n\r\nVision: Creating a world in which observational research produces a comprehensive understanding of health and disease
\r\n\r\nValues: Innovation, Reproducibility, Community, Collaboration, Openness, Beneficence
\r\n\r\nOHDSI strives to develop reliable real-world evidence through methodological research, open-source analytics development, and clinical evidence generation.
", "title": "Observational Health Data Sciences & Informatics" }, "revision_id": 0, "slug": "ohdsi", "updated": "2020-08-31T15:21:54.913394+00:00" }, { "access": { "member_policy": "open", "members_visibility": "restricted", "record_policy": "open", "review_policy": "closed", "visibility": "public" }, "children": { "allow": true }, "created": "2022-11-23T15:53:29.436323+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "id": "f0a8b890-f97a-4eb2-9eac-8b8a712d3a6c", "links": {}, "metadata": { "curation_policy": "The EU Open Research Repository serves as a repository for research outputs (data, software, posters, presentations, publications, etc) which have been funded under an EU research funding programme such as Horizon Europe, Euratom or earlier Framework Programmes.
\nThe community is managed by CERN on behalf of the European Commission.
\nZenodo’s general policies and Terms of Use apply to all content.
\nThe EU Open Research Repository accepts all digital research objects which is a research output stemming from one of EU’s research and innovation funding programmes. The funding programmes currently include:
\nHorizon Europe (including ERC, MSCA), earlier Framework Programmes (eg Horizon 2020) as well as Euratom.
\nIn line with the principle as open as possible, as closed as necessary both public and restricted content is accepted. See note on how Zenodo handles restricted content.
\nEU programme beneficiaries are eligible to submit content to the community. The community supports three types of content submissions:
\nSubmission via an EU Project Community (through user interface or programmatic APIs).
\nSubmission directly to the EU Open Research Repository.
\nAutomated harvesting from existing Zenodo content.
\nA representative of an EU project may request an EU Project Community and invite other project participants as members of the community. The project community is linked to one or more European Commission grants. All records in the project community are automatically integrated into the EU Open Research Repository immediately upon acceptance into the project community.
\nAny user may submit a record directly to the EU Open Research Repository. The submission will be moderated by Zenodo staff for compliance with the minimal required metadata requirements and its correctness.
\nRecords found among Zenodo’s existing content will on a regular basis automatically be integrated if they are found to comply with the requirements. The submissions through this method are integrated into the EU Open Research Repository with delay in a fully automated way.
\nRecords in the EU Open Research Repository are required to comply with the following minimal metadata requirements:
\nVisibility: Both public and restricted (with or without embargo and/or access request)
\nResource types: All resource types.
\nLicenses: Public and embargoed records MUST specify a license.
\nFunding information: Records MUST specify at least one grant from the European Commission.
\nCreators: Creators SHOULD be identified with a persistent identifier (e.g. ORCID, GND, …), and affiliations SHOULD be identified with a persistent identifier (e.g. ROR, ISNI, …)
\nSubjects: Records SHOULD specify one or more fields of science from the European Science Vocabulary.
\nAll submissions will undergo automated curation checks for compliance with the policy. Submissions through project communities are reviewed by the project community. Submission directly to the EU Open Research Repository is reviewed by Zenodo staff.
\nCommunity curators may at any point edit metadata of the records in the community without notice through human or automated processing. The curators may at their sole discretion remove records from the community that are deemed not to comply with the content and curation policy or which are deemed of insufficient quality.
\nThe content and curation policy is subject to change by the community owner at any time and without notice, other than through updating this page.
", "description": "Open repository for EU-funded research outputs from Horizon Europe, Euratom and earlier Framework Programmes.", "organizations": [ { "id": "00k4n6c32" } ], "page": "The EU Open Research Repository is a Zenodo-community dedicated to fostering open science and enhancing the visibility and accessibility of research outputs funded by the European Union. The community is managed by CERN on behalf of the European Commission.
\nThe mission of the repository is to support the implementation of the EU's open science policy, providing a trusted and comprehensive space for researchers to share their research outputs such as data, software, reports, presentations, posters and more. The EU Open Research Repository simplifies the process of complying with open science requirements, ensuring that research outputs from Horizon Europe, Euratom, and earlier Framework Programmes are freely accessible, thereby accelerating scientific discovery and innovation.
\nThe EU Open Research Repository serves as a complementary platform to the Open Research Europe (ORE) publishing platform. Open Research Europe focuses on providing a publishing venue for peer-reviewed articles, ensuring that research meets rigorous academic standards. The EU Open Research Repository provides a space for all the other research outputs including data sets, software, posters, and presentations that are out of scope for ORE. This holistic approach enables researchers to not only publish their findings but also share the underlying data and materials that support their work, fostering transparency and reproducibility in the scientific process.
\nCurrently in its pilot phase and set to be fully operational during autumn 2024, the EU Open Research Repository is constantly evolving. Efforts are committed to integrating cutting-edge features, including automated curation checks and FAIR (Findable, Accessible, Interoperable, and Reusable) assistance, to further support the research community. The goal is to provide researchers with a simple goto solution for making their publicly funded research open and as FAIR as possible.
\nThe EU Open Research Repository is funded by the European Union under grant agreement no. 101122956(HORIZON-ZEN). For more information about the project see https://about.zenodo.org/projects/horizon-zen/.
", "title": "EU Open Research Repository (Pilot)", "type": { "id": "organization" }, "website": "https://research-and-innovation.ec.europa.eu" }, "revision_id": 16, "slug": "eu", "theme": { "brand": "horizon", "enabled": true, "style": { "font": { "family": "Arial, sans-serif", "size": "16px", "weight": 600 }, "mainHeaderBackgroundColor": "#FFFFFF", "primaryColor": "#004494", "primaryTextColor": "#FFFFFF", "secondaryColor": "#FFD617", "secondaryTextColor": "#000000", "tertiaryColor": "#e3eefd", "tertiaryTextColor": "#1c5694" } }, "updated": "2024-03-20T06:47:47.577483+00:00" } ], "ids": [ "0bef1a2b-0c8d-4bb7-afa1-8007d1fb02cc", "90b861a2-0407-4aa9-8525-069533011146", "b363ec34-ac0c-428b-b41a-3b7152593284", "f0a8b890-f97a-4eb2-9eac-8b8a712d3a6c" ] }, "id": "4946541", "pids": {} }, "pids": { "doi": { "identifier": "10.1136/bmj.n1435", "provider": "external" }, "oai": { "identifier": "oai:zenodo.org:4946542", "provider": "oai" } }, "revision_id": 6, "stats": { "all_versions": { "data_volume": 105033360.0, "downloads": 174, "unique_downloads": 162, "unique_views": 198, "views": 250 }, "this_version": { "data_volume": 105033360.0, "downloads": 174, "unique_downloads": 162, "unique_views": 198, "views": 250 } }, "status": "published", "updated": "2021-11-03T20:02:42.166037+00:00", "versions": { "index": 1, "is_latest": true } }